3 Things

Indian PhD scholar's visa revoked, CAR T- cell therapy, and Israel attacks Gaza

Mar 19, 2025

Anona Dutt, a reporter for The Indian Express, dives into the controversial visa revocation of Ranjini Srinivasan, an Indian PhD scholar, amidst escalating tensions surrounding campus protests. Dutt elaborates on the implications for academic freedom and the fear many scholars face. The discussion shifts to groundbreaking results from India's CAR T-cell therapy clinical trials, highlighting its promise in cancer treatment. Lastly, the podcast touches on the escalating violence in Gaza, providing a poignant backdrop to the ongoing crisis.

22:48

Creator website

Episode guests

Anonna Dutt

AI Summary

AI Chapters

Episode notes

Podcast summary created with Snipd AI

Quick takeaways

The revocation of Ranjini Srinivasan's visa highlights increasing restrictions on political expression and foreign nationals in the US academic environment.

India's CAR T-cell therapy shows a promising 73% response rate for difficult-to-treat cancers, marking a significant advancement in personalized cancer treatment.

Deep dives

Revocation of Student Visa Amid Political Tensions

An Indian PhD scholar in the US had her F1 visa revoked due to alleged advocacy for violence and support for Hamas, leading her to self-deport. This incident reflects a broader crackdown by the Trump administration on foreign nationals linked to pro-Palestinian protests across American campuses during the previous spring. These protests, particularly prominent at Columbia University, have been viewed as intimidating towards Jewish students, resulting in increased scrutiny and potential threats to funding for universities. Experts noted that the revocation of her visa is part of a wider effort to tighten control over political speech in academic settings, highlighting a shift in the political climate surrounding immigration and free expression in the US.

Intro

3min

Campus Protests and Rising Tensions at Columbia University

2min

Revocation and Response: The Case of a PhD Scholar

4min

Innovations in Self-Deportation and CAR T-Cell Therapy

9min

Updates on CAR T-Cell Therapy and Gaza Airstrikes

4min

First, we talk to The Indian Express' Divya A about Ranjini Srinivasan, an Indian PhD scholar from Columbia University in the US, whose F-1 student visa was revoked for allegedly advocating for violence and terrorism and supporting Hamas. Fearing action by the authorities, she chose to self-deport and return home.

Next, The Indian Express' Anonna Dutt talks about CAR T- cell therapy or chimeric antigen receptor T-cell therapy, which is a novel treatment method for cancer. She shares how the clinical trial results of India's CAR T-cell therapy were published in the Lancet and more. (11:24)

Lastly, we speak about Israel's biggest assault on the Gaza Strip since the ceasefire on 19th January. (19:28)

Produced and hosted by Niharika Nanda and Shashank Bhargava
Edited and mixed by Suresh Pawar

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

3 Things

Indian PhD scholar's visa revoked, CAR T- cell therapy, and Israel attacks Gaza

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

Deep dives

Revocation of Student Visa Amid Political Tensions

Innovative CAR T-Cell Therapy Development

Escalation of Israeli Military Action in Gaza

Remember Everything You Learn from Podcasts